OMEROS CORP (OMER)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FirstSun Capital Bancorp - FSUN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shutterstock, Inc. - SSTK
Communiqué de presse : Rapport financier semestriel 2026 de Sanofi
Press Release: Sanofi’s half-year financial report for 2026
How CNH precision technology is helping family farms turn data into better decisions
Decent Holding Advances AI-Powered Health Data Infrastructure Alongside Community Healthcare Network Expansion
Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel
Clinical trial NCT07090655 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-04-07 3. primary completion date: 2026-04-01 → 2026-04-07 4. enrollment: 38 → 30 participants 5. enrollment type: ESTIMATED → ACTUAL